Explore All Access
Check if your research matches the topics covered in Expert Opinion on Therapeutic Targets?
- Degree of match
- Common matching concepts
- Additional journal recommendations
Expert Opinion on Therapeutic Targets : Impact Factor & More
eISSN: 1744-7631pISSN: 1472-8222
Share this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
Expert Opinion on Therapeutic Targets Key Metrics
CiteScore 
9.8
H-Index
101
SJR
Q1Pharmacology
SNIP
1.33
Time to Accept
4
Mo
Time to Publish
View Chart Mo
Time to Publish
Sign up now and unlock a detailed chart of Time to publish for this journal
% of papers by time taken from submission to publication
0 to 3 months20%
4 to 6 months58%
7 to 9 months15%
Above 9 months7%
Did you find this useful?
Topics Covered on Expert Opinion on Therapeutic Targets
Cancer
Oxidative stress
Sepsis
Lung cancer
Pathophysiology
Tumor microenvironment
Nrf2 pathway
Guanylate cyclase
Glioblastoma
Central nervous system
Alzheimer's disease
Immune checkpoint
Treatment options
Obstructive sleep apnea
Dysbiosis
Pancreatic cancer
Drug discovery
Rheumatoid arthritis
Immunotherapy
Tam receptors
Expert Opinion on Therapeutic Targets Journal Specifications
| Overview | |
| Publisher | TAYLOR & FRANCIS LTD |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1997 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Expert Opinion on Therapeutic Targets ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Expert Opinion on Therapeutic Targets
Unlocking the potential of melanotransferrin (CD228): implications for targeted drug development and novel therapeutic avenues.
- 15 Dec 2024
- Expert opinion on therapeutic targets
MiR-181a: regulatory roles, cancer-associated signaling pathway disruptions, and therapeutic potential
- 8 Dec 2024
- Expert Opinion on Therapeutic Targets
RSK1 and RSK2 as therapeutic targets: an up-to-date snapshot of emerging data
- 6 Dec 2024
- Expert Opinion on Therapeutic Targets
Targeting mucosal healing in Crohn’s disease: efficacy of novel pathways and therapeutic targets
- 1 Dec 2024
- Expert Opinion on Therapeutic Targets
Druggable genes for therapeutic targeting in PTH signaling for osteoporosis
- 1 Dec 2024
- Expert Opinion on Therapeutic Targets
Lipocalin-2 as a therapeutic target for diabetes neurological complications
- 1 Dec 2024
- Expert Opinion on Therapeutic Targets
Unlocking the potential of melanotransferrin (CD228): implications for targeted drug development and novel therapeutic avenues.
- 15 Dec 2024
- Expert opinion on therapeutic targets
MiR-181a: regulatory roles, cancer-associated signaling pathway disruptions, and therapeutic potential
- 8 Dec 2024
- Expert Opinion on Therapeutic Targets
RSK1 and RSK2 as therapeutic targets: an up-to-date snapshot of emerging data
- 6 Dec 2024
- Expert Opinion on Therapeutic Targets
Targeting mucosal healing in Crohn’s disease: efficacy of novel pathways and therapeutic targets
- 1 Dec 2024
- Expert Opinion on Therapeutic Targets
Druggable genes for therapeutic targeting in PTH signaling for osteoporosis
- 1 Dec 2024
- Expert Opinion on Therapeutic Targets
Lipocalin-2 as a therapeutic target for diabetes neurological complications
- 1 Dec 2024
- Expert Opinion on Therapeutic Targets
Compare Similar Journals with Expert Opinion on Therapeutic Targets
Select Journals to Compare with Expert Opinion on Therapeutic Targets
Total journals - 8
You can select up to 3 Journals at a time
International Journal of Molecular Sciences
Publisher: MDPI
Scientific Reports
Publisher: NATURE PORTFOLIO
Frontiers in Immunology
Publisher: FRONTIERS MEDIA SA
Cancers
Publisher: MDPI
Cancer Research
Publisher: AMER ASSOC CANCER RESEARCH
Cells
Publisher: MDPI
Frontiers in Pharmacology
Publisher: FRONTIERS MEDIA SA
PLoS ONE
Publisher: PUBLIC LIBRARY SCIENCE
0 Journals Selected to compare with
Expert Opinion on Therapeutic Targets
Compare journals across 7 parameters SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
Get detailed Journal comparison report on your email by signing up
FAQs on Expert Opinion on Therapeutic Targets
How long has Expert Opinion on Therapeutic Targets been actively publishing? 
Expert Opinion on Therapeutic Targets has been in operation since 1997 till date.
What is the publishing frequency of Expert Opinion on Therapeutic Targets?
Expert Opinion on Therapeutic Targets published with a Monthly frequency.
How many articles did Expert Opinion on Therapeutic Targets publish last year?
In 2023, Expert Opinion on Therapeutic Targets publsihed 102 articles.
What is the eISSN & pISSN for Expert Opinion on Therapeutic Targets?
For Expert Opinion on Therapeutic Targets, eISSN is 1744-7631 and pISSN is 1472-8222.
What is Citescore for Expert Opinion on Therapeutic Targets?
Citescore for Expert Opinion on Therapeutic Targets is 9.8.
What is the H Index for Expert Opinion on Therapeutic Targets ?
H Index for Expert Opinion on Therapeutic Targets is 101.
What is SNIP score for Expert Opinion on Therapeutic Targets?
SNIP score for Expert Opinion on Therapeutic Targets is 1.33.
What is the SJR for Expert Opinion on Therapeutic Targets?
SJR for Expert Opinion on Therapeutic Targets is Q1.
Who is the publisher of Expert Opinion on Therapeutic Targets?
TAYLOR & FRANCIS LTD is the publisher of Expert Opinion on Therapeutic Targets.
